![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Chemtura Corporation Middlebury Us, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Zinc stearate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2001-008 - Rev 00
This TSE Type CEP, issued on January 25, 2007, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 306 associated with this CEP further emphasizes